Literature DB >> 9771941

Aberrant crypt focus promotion and glucose intolerance: correlation in the rat across diets differing in fat, n-3 fatty acids and energy.

N Koohestani1, M C Chia, N A Pham, T T Tran, S Minkin, T M Wolever, W R Bruce.   

Abstract

McKeown-Eyssen (Cancer Epidemiol. Biomarkers Prevent., 3, 687-695, 1994) and Giovannucci (Cancer Causes Control, 6, 164-179, 1995), noting the striking similarity in lifestyle risk factors for colorectal cancer and insulin resistance, proposed that the hyperinsulinemia, glycemia and hypertriglyceridemia associated with insulin resistance promotes colon cancer. To compare the effect of diet on colon cancer promotion and insulin resistance in the F344 rat, we assessed the effect of fat, n-3 fatty acids and energy in pairwise comparisons on average size of aberrant crypt foci (ACF) and on glucose intolerance in the same animals in a single experiment. Diets high in fat and energy increased and diets with increased n-3 fatty acids and calorie restriction decreased both ACF growth and glucose intolerance compared with control diets. The measures of promotion of colon cancer and insulin resistance were strongly correlated (n = 98, r = 0.67, P < 0.001). In addition, both were highly correlated with daily energy intake (r = 0.62 and 0.66) and were also correlated with basal (post-prandial) insulin, glucose and triglycerides (r = 0.31-0.53, P < 0.01). We concluded that ACF growth and glucose intolerance are correlated for a wide range of diets and that increased circulating energy (glucose and triglycerides) may lead to both colon cancer promotion and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9771941     DOI: 10.1093/carcin/19.9.1679

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  11 in total

1.  Is there an estrogenic component in the metabolic syndrome?

Authors:  S Starcke; G Vollmer
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

2.  Chemopreventive effects of RXR-selective rexinoid bexarotene on intestinal neoplasia of Apc(Min/+) mice.

Authors:  Naveena B Janakiram; Altaf Mohammed; Li Qian; Chang-In Choi; Vernon E Steele; Chinthalapally V Rao
Journal:  Neoplasia       Date:  2012-02       Impact factor: 5.715

Review 3.  Growth hormone, the insulin-like growth factor axis, insulin and cancer risk.

Authors:  Peter E Clayton; Indraneel Banerjee; Philip G Murray; Andrew G Renehan
Journal:  Nat Rev Endocrinol       Date:  2010-10-19       Impact factor: 43.330

4.  Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon.

Authors:  D E Corpet; G Peiffer; S Taché
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

5.  Hypertriglyceridemia is positively correlated with the development of colorectal tubular adenoma in Japanese men.

Authors:  Masafumi Tabuchi; Joji Kitayama; Hirokazu Nagawa
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

6.  A pilot randomised controlled trial to reduce colorectal cancer risk markers associated with B-vitamin deficiency, insulin resistance and colonic inflammation.

Authors:  W R Bruce; M Cirocco; A Giacca; Y-I Kim; N Marcon; S Minkin
Journal:  Br J Cancer       Date:  2005-09-19       Impact factor: 7.640

7.  Gender difference in metabolic syndrome and incident colorectal adenoma: A prospective observational study (KCIS No.42).

Authors:  Mei-Sheng Ku; Sherry Yueh-Hsia Chiu; Kuo-Liong Chien; Yi-Chia Lee; Sam Li-Sheng Chen; Chih-Dao Chen
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 8.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

Review 9.  The metabolic and mitogenic properties of basal insulin analogues.

Authors:  Norbert Tennagels; Ulrich Werner
Journal:  Arch Physiol Biochem       Date:  2013-02       Impact factor: 4.076

10.  Treatment with insulin analog X10 and IGF-1 increases growth of colon cancer allografts.

Authors:  Henning Hvid; Marie-José Blouin; Elena Birman; Jesper Damgaard; Fritz Poulsen; Johannes Josef Fels; Christian Fledelius; Bo Falck Hansen; Michael Pollak
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.